
InNexus Biotechnology, Inc.
InNexus Biotechnology, Inc.(IXSBF)股票概览
关键指标与盈利、估值、营收、股息等标签页深链。
FMP · IXSBF · 截至 Jun 9, 2026
关键指标
探索 InNexus Biotechnology, Inc. 数据
ixsbf stock data · financials财务快照
完整财报竞争对手与同行
ixsbf competitors股票表现
完整历史关于 InNexus Biotechnology, Inc.
InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) …
what is innexus biotechnology, inc. · ixsbf stock overview · innexus biotechnology, inc. company profile · who is innexus biotechnology, inc. ceo · ixsbf OTC · innexus biotechnology, inc. headquarters · innexus biotechnology, inc. business segments
关于股票概览与关键数据
InNexus Biotechnology, Inc.(IXSBF)是 Medical - Pharmaceuticals 行业的 Healthcare 类公司,于 Jan 28, 2005 在 OTC 上市。截至最近交易日,IXSBF 股价为 $0.00,市值约为 $12,627。过去12个月累计回报 +0.00%,年初至今回报 +0.00%。
2010 财年 InNexus Biotechnology, Inc. 营收 —。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。
常见问题
截至最近一个交易日,InNexus Biotechnology, Inc.(IXSBF)股价为 $0.00,在 OTC 上市,52周区间为 $0.00 – $0.00。